Share-based Compensation (Tables)

3 Months Ended

Mar. 31, 2026

2019 Incentive Award Plan

Share-based Compensation

Schedule of stock option activity

		Weighted
		Average
	Number of	Exercise
	Shares	Price
Outstanding, January 1, 2026	47,955	$	720.00
Options granted	—		—
Options forfeited	—		—
Outstanding, March 31, 2026	47,955	$	720.00
Exercisable, March 31, 2026	47,516	$	720.00

Summary of restricted stock units activity

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
Outstanding, January 1, 2026	9,351	$	780.48
Granted	—		—
Vested	—		—
Forfeited	—		—
Outstanding, March 31, 2026	9,351	$	780.48

AEON Biopharma Inc 2023 Incentive Award Plan

Share-based Compensation

Schedule of stock option activity

		Weighted
		Average
	Number of	Exercise
	Shares	Price
Outstanding, January 1, 2026	51,016	$	242.14
Options granted	—		—
Options forfeited	—		—
Outstanding, March 31, 2026	51,016	$	242.14
Exercisable, March 31, 2026	45,160	$	169.94

Summary of restricted stock units activity

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
Outstanding, January 1, 2026	14,215	$	60.05
Granted	10,928,059		1.03
Vested	—		—
Forfeited	—		—
Outstanding, March 31, 2026	10,942,274	$	1.10

2025 Employment Inducement Incentive Award Plan

Share-based Compensation

Schedule of stock option activity

		Weighted
		Average
	Number of	Exercise
	Shares	Price
Outstanding, January 1, 2026	59,034	$	0.41
Options granted	—		—
Options forfeited	—		—
Outstanding, March 31, 2026	59,034		0.41
Exercisable, March 31, 2026	—	$	—

Summary of restricted stock units activity

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
Outstanding, January 1, 2026	672,141	$	0.65
Granted	—		—
Vested	—		—
Forfeited	—		—
Outstanding, March 31, 2026	672,141	$	0.65